Effexor Lawsuit: The Antitrust Settlements Are Approved and Claims Are Closed
Questions about this case?
AI Legal Assistant · free · answers in seconds · general information, not legal advice
The Effexor lawsuit in the news is not about side effects. It is an antitrust case over the price of Effexor XR between 2008 and 2011. Consumers and health plans who paid for it in 21 states were covered by two settlements: $25.5 million from Wyeth and $2.25 million from Teva, both approved by a New Jersey federal court. The claim deadline was July 17, 2025. As of October 2026 there is no open claim form.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Effexor Class Action Alleges
Effexor XR is Wyeth's extended-release venlafaxine, an antidepressant; Wyeth is now part of Pfizer. In November 2005, Wyeth and generic maker Teva settled a patent dispute over generic Effexor XR. Teva launched its generic in July 2010.
Starting in 2011, buyers sued both companies. The lawsuit alleges that the 2005 deal was a “reverse payment” agreement that unlawfully delayed cheaper generic competition, so purchasers overpaid. Effexor XR sales were about $2.6 billion a year at the time, according to Teva's SEC filings. Both companies deny wrongdoing, and Pfizer did not admit any when it settled.
Case Details
The case is In re Effexor XR Antitrust Litigation, No. 3:11-cv-05479, in the U.S. District Court for the District of New Jersey. Judge Peter G. Sheridan granted preliminary approval of the Wyeth consumer settlement, and Judge Zahid N. Quraishi granted final approval of both consumer settlements. Three groups of plaintiffs sued: a proposed class of direct purchasers (wholesalers), a class of indirect purchasers (consumers and health plans) and certain chain pharmacies.
A separate, older case also used the Effexor name: In re Effexor (Venlafaxine Hydrochloride) Products Liability Litigation, MDL No. 2458, No. 13-md-2458 (E.D. Pa.), before Judge Cynthia M. Rufe. It gathered federal birth-defect claims in 2013. On September 16, 2015, the judge recommended that the MDL be stayed because all of its cases had been closed. No class settlement or claim program came out of it.
Status: Consumer Settlements Approved, Deadline Passed
The case is not completely over. Wyeth agreed to pay $39 million to a class of direct purchasers (drug wholesalers), filed for approval in April 2024. Teva's 10-Q for the second quarter of 2026 says the case “is proceeding with respect to the other plaintiffs” — the direct purchasers and the chain pharmacies. Those claims belong to businesses that bought from the manufacturers, not to patients. We could not confirm whether checks to consumer claimants have been mailed yet.
Who Was Covered by the Effexor Settlement
The consumer and health-plan class covered people and third-party payors who paid for brand Effexor XR or an AB-rated generic between June 14, 2008 and May 31, 2011, in these states: Arizona, California, Florida, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nevada, New Hampshire, New Mexico, New York, North Carolina, Oregon, Rhode Island, South Dakota, Tennessee, West Virginia and Wisconsin.
Claims required proof, such as pharmacy or insurance records, an explanation-of-benefits statement, a doctor's note or receipts. People who filed for the Wyeth settlement did not need to file again for Teva. If you did not file by July 17, 2025, you cannot file now. If you did file, the administrator, A.B. Data, handles payments. The official site is effexorxrindirectsettlement.com.
How Much the Effexor Settlement Pays
Realistically, a few million dollars for consumers, split among many claimants, means modest individual checks. Approved claimants are paid by paper check mailed to the address on the claim form. If you filed and moved, update your address with the administrator. See our guide to settlement check problems for what to do if a payment seems late or lost.
How cases like this one end
Our copy of the federal courts’ own case database covers 6,659 antitrust casesclosed in U.S. federal district courts between 2015 and 2025, 37.3% of them filed as class actions:
- 19.7% ended in a settlement recorded by the court. Another 14.4% were dismissed voluntarily, which often follows a private settlement — so the real settlement share sits between 19.7% and 34.1%.
- 11.6% were decided on a motion before any trial.
- 1 in 121 reached a trial (0.8%), after a median of 37 months.
- Median time from filing to the end of the case: 12.3 months.
- Almost none record a money award in this data (32 of 6,659), and the recorded figures are capped, so we do not publish an average.
These are base rates for this type of case (federal antitrust cases) — not a prediction about this lawsuit, and not legal advice. Source: Federal Judicial Center, Integrated Database (civil), analysed by Settlement Insight. Cases heard in state courts are not included.
Effexor Lawsuit Timeline
- 1
November 2005 — Wyeth and Teva Settle Their Patent Fight
The two companies resolve patent litigation over generic Effexor XR. That deal is what the later antitrust suits attack.
- 2
July 2010 — Generic Effexor XR Launches
Teva launches its generic version. Effexor XR sales were about $2.6 billion a year at the time.
- 3
2011 — Antitrust Suits Filed in New Jersey
Direct purchasers, indirect purchasers and chain pharmacies sue Wyeth and Teva. The cases proceed as No. 3:11-cv-05479 in the District of New Jersey.
- 4
September 12, 2024 — Wyeth Consumer Settlement Approved
Judge Zahid N. Quraishi grants final approval of the $25.5 million Wyeth settlement.
- 5
July 17 and August 19, 2025 — Claims Close, Teva Deal Approved
The claim deadline passes on July 17, 2025. On August 19, 2025, the court grants final approval of Teva's $2.25 million settlement.
- 6
October 2026 — Remaining Claims Pending
No consumer claim form is open. The direct purchaser and chain pharmacy claims are still proceeding, according to Teva's 2026 filings.
Three Things to Watch For
A closed settlement for a widely used antidepressant attracts imitators:
“Late Effexor claims still accepted” pages
The deadline was July 17, 2025. A site offering to file a new Effexor XR claim today, especially one asking for your Social Security number or bank login, is not the court-approved process.
Side-effect ads dressed up as a settlement
Ads promoting an “Effexor memory loss lawsuit” or withdrawal claims are lead-generation for law firms. They are not the antitrust settlement and do not pay anyone. We found no court case number behind these ads.
Fees to “release” your check
Court-approved administrators do not charge class members to receive payment. If someone asks for a processing fee or gift cards before releasing your Effexor payment, it's a scam. Contact the administrator only through the official site.
Effexor Lawsuit — Questions People Actually Ask
What is the Effexor class action lawsuit about?
It is an antitrust case, In re Effexor XR Antitrust Litigation, No. 3:11-cv-05479 (D.N.J.). It alleges that Wyeth and Teva's 2005 patent settlement delayed generic Effexor XR, so buyers overpaid. It is not a side-effect case. Both companies deny wrongdoing.
Is there an Effexor settlement I can still claim?
No. The consumer and health-plan claim deadline was July 17, 2025. The $25.5 million Wyeth settlement and the $2.25 million Teva settlement are both finally approved. If you filed on time, your payment comes from the administrator, A.B. Data.
Is there a class action lawsuit Effexor users can join for side effects?
Not that we could verify. The federal birth-defect MDL, No. 2458, closed its cases by 2015. As of October 2026 we found no certified class action against Effexor for withdrawal or memory problems. Individual injury claims are handled case by case with a lawyer, not through a claim form.
Who could file a claim?
Consumers and third-party payors who paid for brand or AB-rated generic Effexor XR between June 14, 2008 and May 31, 2011 in 21 listed states. These included California, Florida, New York, Michigan and Massachusetts. Proof of purchase was required.
How much will I get from the Effexor settlement?
No fixed amount. Shares are pro rata, based on how much you bought and how many claims were filed. Consumers share 22% of the net fund and health plans share 78%. Payments go out by paper check.
Is there an Effexor class action lawsuit Canada residents can join?
We found no record of an Effexor class action lawsuit in Canada. The U.S. settlement covered only purchases in the 21 listed U.S. states, so Canadian purchases were not included.
Is the class action lawsuit against Effexor's makers over?
Not entirely. Consumers and health plans have settled. Wyeth agreed to pay $39 million to direct purchasers (wholesalers). Teva's 2026 filings say the case is still proceeding for the other plaintiffs, which are businesses rather than patients.
I got an email about an Effexor payment. Is it real?
It can be, if you filed a claim. Check that it matches the official site, effexorxrindirectsettlement.com, and never pay a fee to receive your money. If you never filed a claim, you are not owed a payment from these settlements.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.
Related Consumer Brand Lawsuits
Open Class Action Settlements
Settlements still accepting claims, with deadlines
A.B. Data Class Action Administration
The administrator named on the Effexor XR consumer claims
Settlement Check Problems
What to do when a settlement payment is late or lost
Settlement Payout Calculator
Estimate what a pro rata class settlement pays per person